Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy (Q44635664)

4 December 2017

title

Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy (English)

1 reference

4 December 2017

1 reference

6

1 reference

4 December 2017

10

März W

1 reference

4 December 2017

Winkelmann BR

1

1 reference

4 December 2017

Hoffmann MM

2

1 reference

4 December 2017

Nauck M

3

1 reference

4 December 2017

Kumar AM

4

1 reference

4 December 2017

Nandabalan K

5

1 reference

4 December 2017

Boehm BO

7

1 reference

4 December 2017

Tall AR

8

1 reference

4 December 2017

Ruaño G

9

1 reference

4 December 2017

publication date

1 January 2003

1 reference

The Pharmacogenomics Journal

4 December 2017

published in

1 reference

4 December 2017

volume

3

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

284-296

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500195

4 December 2017

exact match

0 references

cites work

The evolving role of statins in the management of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Organization of the human cholesteryl ester transfer protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Drug treatment of lipid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Current perspectives on statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Effect of apoE genotype on the hypolipidaemic response to pravastatin in an outpatient setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Elevated baseline triglyceride levels modulate effects of HMGCoA reductase inhibitors on plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

High density lipoproteins and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Haplotype variation and linkage disequilibrium in 313 human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

How many SNPs does a genome-wide haplotype map require?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Haplotype tagging for the identification of common disease genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

Plasma lipid transfer proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Heterogeneity at the CETP Gene Locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Genetic factors associated with response of LDL subfractions to change in the nature of dietary fat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

A polymorphic site in the 3' untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

A time to stop prescribing antioxidant vitamins to prevent and treat heart disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Metabolic modes of action of the statins in the hyperlipoproteinemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500195

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500195

1 reference

4 December 2017

1 reference